McCann Health Engagement
As a media agency exclusively focused on healthcare, McCann Health Engagement has deep knowledge and vast experience planning and buying in the pharmaceutical industry specific to HCP and DTC on a global scale. We have experience working on almost every therapeutic category within the healthcare and pharmaceutical landscape.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
CMI Media Group
CMI Media Group, a WPP company, is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and…
Four Agency Worldwide
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with content creators, PR gurus with advertising geniuses & sector specialists…
Havas Lynx
We are the Havas Lynx. Devoted to fresh thinking. Changing the way the world does healthcare communications for the better. Great talent. Great ideas. Great outcomes.
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
Company Details
Latest Content from PMHub
Season’s Greetings
Videos and Podcasts | December 19, 2018 | Cuttsy + Cuttsy
Do you have Tinsilitus?
Lucid Winter Meeting 2018
Videos and Podcasts | December 18, 2018 | Lucid Group Communications Limited
The teams gathered at The Artisan in Clerkenwell, London, to reflect on the year and celebrate both team and individual contributions to Lucid, their clients and the local community through...
2018 was a magical year for Lucid Group, filled with memorable moments and many celebrations
Press Releases | December 18, 2018 | Lucid Group Communications Limited
This year has been a ground-breaking year for Lucid Group, punctuated by magical makeovers, plenty of awards, landmark staff celebrations and worthwhile charity work.The tone of the year was set...
We’ve moved!
Press Releases | December 14, 2018 | Blue Latitude Health
Blue Latitude Health has moved office to a new location in Barbican, Central London, following a year of substantial growth.
New editor adds microscopic attention to detail at Porterhouse Medical
Press Releases | December 13, 2018 | Porterhouse Medical Group
The Porterhouse Medical Group is delighted to welcome Isabel Thomas to our scientific services team in Reading.Joining us as an associate editor, Isabel will be working closely alongside Stephanie, senior editor, to boost...
Navigating the antibiotic resistance crisis
White Papers and Resources | December 13, 2018 | Blue Latitude Health
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Blue Latitude Health joins Fishawack Group of Companies
Press Releases | December 12, 2018 | Blue Latitude Health
Blue Latitude Health announces a new partnership with Fishawack Group of Companies, fuelling our global growth.
Healthcare excellence celebrated at 2018 HSJ Awards
Press Releases | December 11, 2018 | Wilmington Healthcare
Thousands of healthcare professionals were in attendance, all eager to scoop one of the coveted prizes from the world’s largest healthcare awards programme.
Report: Achieving launch excellence in the challenging healthcare markets of today
White Papers and Resources | December 10, 2018 | Blue Latitude Health
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
NHS medicines optimisation milestone
White Papers and Resources | December 10, 2018 | Wilmington Healthcare
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry